2R of thymidylate synthase 5'-untranslated enhanced region contributes to gastric cancer risk: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 1923-1927

  Yang, Zhen ^a   Liu, Hong Xiang ^a   Zhang, Xie Fu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Asians; Caucasians; Gastric cancer; Meta analysis; Polymorphism; Thymidylate synthase

Indexed keywords

THYMIDYLATE SYNTHASE;

5' UNTRANSLATED REGION; ARTICLE; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; PROGNOSIS; STOMACH TUMOR;

5' UNTRANSLATED REGIONS; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PROGNOSIS; STOMACH NEOPLASMS; THYMIDYLATE SYNTHASE;

EID: 84872681950     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.1923     Document Type: Article

References (27)

1. Carreras CW, Santi DV (1995). The catalytic mechanism and structure of thymidylate synthase. Ann Rev Biochem, 64, 721-62.
2. Cochran WG (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29.
3. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
4. Egger M, Davey Smith G, Schneider M, et al (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
5. Graziano F, Kawakami K, Watanabe G, et al (2004). Association of thymidylate synthase polymorphisms with gastric cancer susceptibility. Int J Cancer, 112, 1010-4.
6. Hardy LW, Finer-Moore JS, Montfort WR, et al (1987). Atomic structure of thymidylate synthase: target for rational drug design. Science, 235, 448-55.
7. Hartgrink HH, Jansen EP, van Grieken NC, et al (2009). Gastric cancer. Lancet, 374, 477-90.
8. Higgins JP, Thompson SG, Deeks JJ, et al (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60.
9. Higgins J, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
10. Horie N, Aiba H, Oguro K, et al (1995). Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase. Cell Struct Funct, 20, 191.
11. Ho V, Massey TE, King WD (2011). Thymidylate synthase gene polymorphisms and markers of DNA methylation capacity. Mol Genet Metab, 102, 481-7.
12. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
13. Lin D, Li H, Tan W, et al (2007). Genetic polymorphisms in folate- metabolizing enzymes and risk of gastroesophageal cancers: a potential nutrient-gene interaction in cancer development. Forum Nutr, 60, 140-5.
14. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
15. Marsh S, McKay JA, Cassidy J, et al (2001). Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer. Int J Oncol, 19, 383-6.
16. Resende C, Ristimaki A, Machado JC (2010). Genetic and epigenetic alteration in gastric carcinogenesis. Helicobacter, 15 Suppl 1, 34-9.
17. Stuck AE, Rubenstein LZ, Wieland D (1998). Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 469.
18. Tan W, Miao X, Wang L, et al (2005). Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. Carcinogenesis, 26, 1430.
19. Tobias A (1999). Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull, 8, 15-7.
20. Trinh BN, Ong CN, Coetzee GA, et al (2002). Thymidylate synthase: a novel genetic determinant of plasma homocysteine and folate levels. Hum Genet, 111, 299-302.
21. Vogelstein B, Kinzler KW (2004). Cancer genes and the pathways they control. Nat Med, 10, 789-99.
22. Wang J, Wang B, Bi J, Di J (2010). The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 128, 203-9.
23. Wang LD, Guo RF, Fan ZM, et al (2005). Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. Dis Esophagus, 18, 177-84.
24. Wroblewski LE, Peek RM, Jr., Wilson KT (2010). Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev, 23, 713-39.
25. Yim DJ, Kim OJ, An HJ, et al (2010). Polymorphisms of thymidylate synthase gene 5'- and 3'-untranslated region and risk of gastric cancer in Koreans. Anticancer Res, 30, 2325-30.
26. Zhang J, Cui Y, Kuang G, et al (2004). Association of the thymidylate synthase polymorphisms with esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Carcinogenesis, 25, 2479-85.
27. Zhang Z, Xu Y, Zhou J, et al (2005). Polymorphisms of thymidylate synthase in the 5'-and 3'-untranslated regions associated with risk of gastric cancer in South China: a case~-control analysis. Carcinogenesis, 26, 1764-9.